Last checked at 21 Jan 2019 14:20
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
21 January 2019
Accrol Group Holdings plc
("Accrol" or the "Company")
AIM: ACRL
Regulatory Investigation
The Financial Conduct Authority (the "FCA") has notified Accrol that it has commenced an investigation into the Company relating to certain statements that it made to the market between 1 April 2017 and 20 November 2017. Accrol is cooperating fully with the FCA.
The Company will issue its Half Year Results for the six months ended 31 October 2019 tomorrow, as previously announced.
For further information, please contact: |
|
|
|
Accrol Group Holdings plc |
|
Dan Wright, Executive Chairman | Tel: +44 (0) 1254 278 844 |
Gareth Jenkins, Chief Executive Officer |
|
|
|
Zeus Capital Limited (Nominated Adviser & Broker) |
|
Dan Bate / Andrew Jones | Tel: +44 (0) 161 831 1512 |
Dominic King / John Goold | Tel: +44 (0) 203 829 5000 |
|
|
Belvedere Communications Limited |
|
Cat Valentine (cvalentine@belvederepr.com) | Tel: +44 (0) 7715 769 078 |
Keeley Clarke (kclarke@belvederepr.com) | Tel: +44 (0) 7967 816 525 |
Notes to Editors
Accrol Group Holdings plc, based in Lancashire, is a leading tissue converter and supplier of toilet rolls, kitchen rolls and facial tissues, as well as other tissue products, to major discounters and grocery retailers throughout the UK.
Accrol operates from three sites:
· A manufacturing, storage and distribution facility in Blackburn;
· A facial tissue plant, also in Blackburn; and
· A manufacturing, storage and distribution facility in Leyland.